Medical Properties Trust, Inc. (NYSE: MPT) filed its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2026, reporting a net loss of $2.6 million attributable to common stockholders in the second quarter and net income of $30.2 million for the first half of the year.

Key Highlights

  • Q2 net loss: Net loss attributable to MPT common stockholders was $2,595 thousand, or $0.01 per basic and diluted share, for the three months ended June 30, 2026.
  • Six-month net income: Net income attributable to MPT common stockholders was $30,232 thousand, or $0.05 per basic and diluted share, for the six months ended June 30, 2026.
  • Total revenues: Total revenues were $259,283 thousand for Q2 2026, compared to $240,359 thousand for Q2 2025, according to the filing.
  • Total assets: Total assets stood at $14,747,740 thousand as of June 30, 2026, down from $15,001,775 thousand at December 31, 2025.
  • Debt level: Debt, net was reported at $9,704,996 thousand as of June 30, 2026.
  • Dividends declared: Dividends declared per common share were $0.09 for Q2 2026 and $0.18 for the six months ended June 30, 2026.
  • Shares outstanding: As of August 10, 2026, the company had 597.2 million shares of common stock outstanding.

Medical Properties Trust Q2 2026 Financial Results and Balance Sheet Position

Medical Properties Trust, Inc. reported total revenues of $259,283 thousand for the three months ended June 30, 2026, compared to $240,359 thousand in the same period of 2025, according to the filing. Revenue components included rent billed of $203,400 thousand, straight-line rent of $33,308 thousand, income from financing leases of $10,081 thousand, and interest and other income of $12,494 thousand. Total expenses for Q2 2026 were $250,688 thousand, including interest expense of $135,262 thousand, real estate depreciation and amortization of $69,453 thousand, and general and administrative costs of $34,771 thousand.

The company disclosed net real estate and other impairment charges of $16,768 thousand in Q2 2026 and $35,800 thousand for the six months ended June 30, 2026. For the comparable six-month period of 2025, impairment charges were $77,523 thousand, according to the filing. Earnings from equity interests were $11,408 thousand for Q2 2026, compared to $25,324 thousand for Q2 2025. The "Other" line item, which the filing describes as including fair value adjustments on securities, reflected a charge of $1,908 thousand in Q2 2026, versus a charge of $124,434 thousand in Q2 2025.

On the balance sheet, net investment in real estate assets was $10,914,332 thousand at June 30, 2026. Cash and cash equivalents were $396,558 thousand, compared to $540,859 thousand at December 31, 2025. Total stockholders' equity attributable to Medical Properties Trust, Inc. was $4,498,849 thousand as of June 30, 2026, with a retained deficit of $4,214,216 thousand. The filing notes that preferred stock authorized was 10,000 thousand shares, with no shares outstanding.

What Was Disclosed

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. jointly filed a Form 10-Q covering the quarterly period ended June 30, 2026, disclosing income statements, balance sheets, and cash flow data for the second quarter and first half of fiscal year 2026.